Cybin Irl Limited

This study tests whether a new drug, CYB003, can safely and effectively reduce depression symptoms in adults with moderate-to-severe major depressive disorder. About 330 participants will receive either one of two doses of CYB003 or a placebo, added to their current antidepressan…

This study tests an experimental oral drug called CYB003 for people with major depressive disorder. The goal is to see if it safely reduces depression symptoms better than a placebo. About 220 adults aged 18 to 85 with moderate to severe depression are being recruited. Participan…